BEAMing and Breast cancer

Publications Breast Cancer

Baselga J, Im S-A, Iwata H, et al. (2015) PIK3CA status in circulating tumor DNA (ctDNA) predicts efficacy of buparlisib (BUP) plus fulvestrant (FULV) in postmenopausal women with endocrine-resistant HR+/HER2– advanced breast cancer (BC): First results from the randomized, phase III BELLE-2 trial. SABCS2015/S6-01
Abstract

Higgins M, Jelovac D, Barnathan E, et al. (2012) Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clin Cancer Res. 2012 Jun 15;18(12):3462-9
Pubmed
Free PDF

Our BEAMing Technology

Principle of Blood-based Testing

The value of ctDNA

Publications

The BEAMing technology

Method papers

The BEAMing technology

Concordance studies

BEAMing and mCRC

Publications

BEAMing and NSCLC

Publications

BEAMing and Melanoma

Publications

Find your job at Sysmex Inostics
Check out our latest news
Contact Sysmex
Contact us!